Skip to content

Herhaalde biomarker metingen rondom extubatie op de Intensive Care

The value of repeated BIOMarker measurements during an SBT to predict EXtubation failure in mechanically ventilated ICU patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25054
Enrollment
266
Registered
2021-02-09
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients admitted to the ICU who are mechanically ventilated for >24h.

Interventions

Not applicable.

Sponsors

Roche Diagnostics International Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Aged =18 years - Mechanically ventilated for >24h - Fulfilling readiness-to wean criteria - Written informed consent from the patient or his/her first representative

Exclusion criteria

Exclusion criteria: - Patients with risk factors for laryngeal oedema and a negative cuff leak test, performed after a successful SBT (indicating upper airway obstruction with need for steroid treatment) - Planned replacement of the endotracheal tube for a tracheostomy - Terminal illness

Design outcomes

Primary

MeasureTime frame
Extubation failure within 48 hours, composed of: -Reintubation, or -Rescue non-invasive ventilation or high-flow nasal oxygen for post-extubation respiratory insuf-ficiency, or -All-cause mortality

Secondary

MeasureTime frame
- Extubation failure within 72h and 1 week - ICU length of stay post-extubation for medical reasons - ICU re-admission rate within current hospitalisation - All-cause mortality: ICU, 28-days, hospital, 3 and 12 months - Long-term follow-up at 3 and 12 months: major adverse cardiovascular events (total death, myocardial infarction, coronary revascularization, stroke, and hospitalization because of heart failure or arrhythmia), Quality of life (RAND-36 and EQ-5D).

Contacts

Public ContactVivan Baggen

Erasmus MC

v.baggen@erasmusmc.nl0651696541

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)